Heart disease is still a primary emphasis
- PMID: 21603440
- PMCID: PMC3096288
Heart disease is still a primary emphasis
Similar articles
-
Eplerenone and atrial fibrillation in mild systolic heart failure: results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure) study.J Am Coll Cardiol. 2012 May 1;59(18):1598-603. doi: 10.1016/j.jacc.2011.11.063. J Am Coll Cardiol. 2012. PMID: 22538330 Clinical Trial.
-
Clinical benefit of eplerenone in patients with mild symptoms of systolic heart failure already receiving optimal best practice background drug therapy: analysis of the EMPHASIS-HF study.Circ Heart Fail. 2013 Jul;6(4):711-8. doi: 10.1161/CIRCHEARTFAILURE.112.000173. Epub 2013 Apr 26. Circ Heart Fail. 2013. PMID: 23625945 Clinical Trial.
-
Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure).J Am Coll Cardiol. 2013 Oct 22;62(17):1585-93. doi: 10.1016/j.jacc.2013.04.086. Epub 2013 Jun 27. J Am Coll Cardiol. 2013. PMID: 23810881 Clinical Trial.
-
Heart anatomy and developmental biology.Experientia. 1988 Dec 1;44(11-12):910-9. doi: 10.1007/BF01939884. Experientia. 1988. PMID: 3058498 Review.
-
Physiopathology of the embryonic heart (with special emphasis on hypoxia and reoxygenation).Ann Cardiol Angeiol (Paris). 2006 Apr;55(2):79-89. doi: 10.1016/j.ancard.2006.02.007. Ann Cardiol Angeiol (Paris). 2006. PMID: 16708991 Review.
References
-
- Lavie C. J., Milani R. V., Ventura H. O. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol. 2009;53:1925–1932. - PubMed
-
- Milani R. V., Lavie C. J., Mehra M. R. Reduction in C-reactive protein through cardiac rehabilitation and exercise training. J Am Coll Cardiol. 2004;43:1056–1061. - PubMed
-
- Milani R. V., Lavie C. J. Prevalence and profile of metabolic syndrome in patients following acute coronary events and effects of therapeutic lifestyle change with cardiac rehabilitation. Am J Cardiol. 2003;92:50–54. - PubMed
-
- Lavie C. J., Milani R. V., Verma A., O'Keefe J. H. C-reactive protein and cardiovascular disease: is it ready for primetime? Am J Med Sci. 2009;338:486–492. - PubMed
-
- Milani R. V., Lavie C. J., Mehra M. R., Ventura H. O., Kurtz J. D., Messerli F. H. Left ventricular geometry and survival in patients with normal left ventricular ejection fraction. Am J Cardiol. 2006;97:959–963. - PubMed
LinkOut - more resources
Full Text Sources